Farmako logo
HomeMedicine DeliveryABDM
Decorative illustration
HomeMedicine DeliveryABDM
footer illustration
HomePrivacy PolicyTerms & Conditions
Download the App
play-storeapp-store
Copyright Farmako Healthcare Private Limited © 2025 All rights reserved
facebooktwitterlinkedininstagram
medicine
medicine
medicine

Menactra Vaccine

vial of 1.0 Solution for Injection
Prescription Required
30 minute delivery
vial of 1.0 Solution for Injection
₹ 5440.00
Get it on upto a 20% discount on Farmako
Delivering to
Out of Stock
Ask Life AI anything about this medicine
Tell me about medicines!

Salt Composition

Meningococcal Vaccine (Group A, C, Y & W-135) (16mcg) + Diphtheria Toxoid (48mcg)

Key InformationDirections for UseSafety InformationHow it worksQuick Tips

Salt Composition

Meningococcal Vaccine (Group A, C, Y & W-135) (16mcg) + Diphtheria Toxoid (48mcg)

Key Information

Short Description

Menactra Vaccine is used to prevent meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135.

Dosage Form

Vaccine

Introduction

Menactra Vaccine is given by a healthcare professional and should not be self-administered. It is important to receive all the doses of the vaccine to be effective. A single booster dose may be given to individuals 15 through 55 years of age at continued risk for meningococcal disease if at least 4 to 6 years have elapsed since the prior dose. Do not administer this product intravenously, subcutaneously, or intradermally.

Directions for Use

Your doctor or nurse will guide you on how to use this medicine.

Safety Information

Side Effects

Some common side effects of this medicine include injection site reactions (such as pain, swelling, redness), irritability, loss of appetite, sleepiness, headache, nausea, vomiting, and diarrhea.

Breastfeeding Warning

Breastfeeding Warning

Pregnant and breastfeeding mothers should consult and seek advice from their doctor before receiving the vaccine.

Pregnancy Warning

Pregnancy Warning

Pregnant and breastfeeding mothers should consult and seek advice from their doctor before receiving the vaccine.

How it works

Menactra Vaccine contains Meningococcal Polysaccharides of serogroups A, C, Y, and W-135 antigens. It also contains diphtheria toxoid protein that acts as a carrier for the individual serogroup antigens. This vaccine helps develop immunity by initiating a mild infection. This type of infection does not cause illness but stimulates the body's immune system to produce antibodies (proteins) to protect against any future infections.

Quick Tips

Menactra Vaccine is used for active immunization to prevent meningococcal disease in individuals 9 months through 55 years of age. In children 9 through 23 months of age, it is given as a 2-dose series at least three months apart. In individuals 2 through 55 years of age, it is given as a single dose. Menactra Vaccine is given by a healthcare professional and should not be self-administered.

Short Description

Menactra Vaccine is used to prevent meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y, and W-135.

Dosage Form

Vaccine

Introduction

Menactra Vaccine is given by a healthcare professional and should not be self-administered. It is important to receive all the doses of the vaccine to be effective. A single booster dose may be given to individuals 15 through 55 years of age at continued risk for meningococcal disease if at least 4 to 6 years have elapsed since the prior dose. Do not administer this product intravenously, subcutaneously, or intradermally.
Your doctor or nurse will guide you on how to use this medicine.

Side Effects

Some common side effects of this medicine include injection site reactions (such as pain, swelling, redness), irritability, loss of appetite, sleepiness, headache, nausea, vomiting, and diarrhea.
Breastfeeding Warning

Breastfeeding Warning

Pregnant and breastfeeding mothers should consult and seek advice from their doctor before receiving the vaccine.
Pregnancy Warning

Pregnancy Warning

Pregnant and breastfeeding mothers should consult and seek advice from their doctor before receiving the vaccine.
Menactra Vaccine contains Meningococcal Polysaccharides of serogroups A, C, Y, and W-135 antigens. It also contains diphtheria toxoid protein that acts as a carrier for the individual serogroup antigens. This vaccine helps develop immunity by initiating a mild infection. This type of infection does not cause illness but stimulates the body's immune system to produce antibodies (proteins) to protect against any future infections.
Menactra Vaccine is used for active immunization to prevent meningococcal disease in individuals 9 months through 55 years of age. In children 9 through 23 months of age, it is given as a 2-dose series at least three months apart. In individuals 2 through 55 years of age, it is given as a single dose. Menactra Vaccine is given by a healthcare professional and should not be self-administered.
India' first 30 minutes
medicine delivery service
percentage
Get atleast 20% discount on all medicines
shield
We always ensure genuine medicines and qualified doctors
deliver
Completed over 2 lakhs super-fast deliveries